Ns Partners LTD Edwards Lifesciences Corp Transaction History

Ns Partners LTD

$2.36 Billion
Q3 2024

A detailed history of Ns Partners LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ns Partners LTD holds 208,641 shares of EW stock, worth $14.9 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

208,641

Previous 204,471 2.04%

Holding current value

$14.9 Million

Previous $18.9 Million 27.1%

% of portfolio

0.58%

Previous 0.86%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$59.7 - $93.78 $248,949 - $391,062	4,170 Added 2.04%	208,641 $13.8 Million
Q2 2024 Aug 08, 2024	BUY	$84.3 - $94.31 $63,730 - $71,298	756 Added 0.37%	204,471 $18.9 Million
Q1 2024 May 09, 2024	SELL	$72.54 - $95.56 $292,118 - $384,820	-4,027 Reduced 1.94%	203,715 $19.5 Million
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $21,721 - $27,371	352 Added 0.17%	207,742 $15.8 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $41,775 - $56,308	-603 Reduced 0.29%	207,390 $14.4 Million
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $124,638 - $144,419	-1,531 Reduced 0.73%	207,993 $19.6 Million
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $29,852 - $33,973	402 Added 0.19%	209,524 $17.3 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $910,712 - $1.17 Million	13,334 Added 6.81%	209,122 $15.6 Million
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $2.2 Million - $2.87 Million	-26,723 Reduced 12.01%	195,788 $16.2 Million
Q2 2022 Aug 05, 2022	BUY	$86.5 - $128.27 $3.12 Million - $4.63 Million	36,099 Added 19.37%	222,511 $21.2 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $764,292 - $962,036	-7,496 Reduced 3.87%	186,412 $21.9 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $65,736 - $80,760	618 Added 0.32%	193,908 $25.1 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $88,605 - $105,687	861 Added 0.45%	193,290 $21.9 Million
Q2 2021 Aug 02, 2021	BUY	$83.84 - $104.76 $60,532 - $75,636	722 Added 0.38%	192,429 $19.9 Million
Q1 2021 Apr 30, 2021	SELL	$78.68 - $90.67 $613,861 - $707,407	-7,802 Reduced 3.91%	191,707 $16 Million
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $139,365 - $177,351	1,944 Added 0.98%	199,509 $18.2 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $528,516 - $687,803	7,866 Added 4.15%	197,565 $15.8 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $7.3 Million - $9.76 Million	126,804 Added 201.61%	189,699 $13.1 Million
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $1 Million - $1.55 Million	19,091 Added 43.58%	62,895 $11.9 Million
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $788 - $902	-11 Reduced 0.03%	43,804 $10.2 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $77,676 - $95,192	1,262 Added 2.97%	43,815 $9.64 Million
Q2 2019 Aug 07, 2019	BUY	$55.74 - $64.41 $472,842 - $546,390	8,483 Added 24.9%	42,553 $7.86 Million
Q4 2018 Feb 12, 2019	BUY	$46.41 - $56.94 $456,906 - $560,574	9,845 Added 40.64%	34,070 $5.22 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $1.11 Million - $1.41 Million	24,225 New	24,225 $4.22 Million

Others Institutions Holding EW

# of Institutions

1,349

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ns Partners LTD with notifications on news.

Account